Reducing the door-to-needle time, allowing quicker treatment with alteplase, is actually associated with a reduced risk of complications linked to thrombolytic use, specialists have reported.
Reducing the door-to-needle time, allowing quicker treatment with alteplase, is actually associated with a reduced risk of complications linked to thrombolytic use, specialists have reported.